AGC Biologics’ Post

Join Luca Alberici and I as we lead an exciting a roundtable discussion on Thursday, November 16, which will feature our team of experts alongside other prominent figures in the industry. This session will provide valuable insights for devising strategies to navigate the intricate landscape of the gene therapy sector in light of financial challenges and regulatory changes. The current economic instability has caused a slowdown in investments within the advanced therapy medicinal product sector (ATMP). In order to remain competitive and successfully introduce new gene therapies based on viral vectors to the market, ATMP companies must adapt their business strategies to secure more resources and optimize cost-effectiveness.   Register for the webinar now to learn how to make informed strategic business decisions while also fostering a deeper understanding of the scientific aspects of gene therapy products. https://lnkd.in/dApuDhPn   AGC Biologics #CDMO #biotech #pharmaceuticals #LifeScience #Biotechnology #advancedtherapies #Biopharmaceuticals  

Thoughts on this? >> Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products - BioBuzz >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharma #pharmaceutical #healthcare

As a GMP Manufacturing team, one of the main goals is to be flexible. Requests and strategies can change greatly between clients, leaving no room for error. AGC Biologics' Sabrina Cazzaniga emphasizes the importance of accommodations in the cell and gene therapy field, and what it takes to get therapies to the market. View the comments for additional resources about cell and gene therapies. #biotech #pharmaceuticals #Genetherapy #viralvectors #LifeScience #ATMPs #Biotechnology #advancedtherapies #Biopharmaceuticals #biopharma #pharma #AGCBio #CDMO

Thoughts on this? >> The Benefit of Long-Read Sequencing in Gene Therapies - Pharmaceutical Technology Magazine >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #pharma #biotech #healthcare

Thoughts on this? >> The Benefit of Long-Read Sequencing in Gene Therapies - Pharmaceutical Technology Magazine >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #healthcare #pharmaceutical

Thoughts on this? >> Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products - BioBuzz >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #pharma #healthcare #biotech

Thoughts on this? >> ReciBioPharm partners with GeneVentiv on first AAV-based gene therapy for hemophilia - The Pharma Letter >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare

Thoughts on this? >> Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth - KFGO >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #healthcare #pharma #biotech

Thoughts on this? >> ReciBioPharm partners with GeneVentiv on first AAV-based gene therapy for hemophilia - The Pharma Letter >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #competitivemarketing #pharmaceutical #biotech

Thoughts on this? >> 2seventy Bio Shares Fall on Concerns About FDA Panel's Meeting on Abecma Gene Therapy - Morningstar >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #competitivemarketing #biotech